← Evidence map

ArticleLung India : official organ of Indian Chest Society2025

Improving patient outcomes: Mepolizumab's impact in IL-5-mediated diseases.

Dipti Gothi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40296395